Verquvo (Vericiguat)
- Medicine Name: Vyndaqel
- Generic Name: Tafamidis Meglumine
- Dosage Form & Strength: Capsules: 20 mg
- Manufactured By: Pfizer Inc.
Medical Uses
Vyndaqel is a transthyretin stabilizer used for the treatment of the heart disease (cardiomyopathy) of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adult patients to decrease the cardiovascular mortality and cardiovascular-related hospitalization.
Recommended Dosage: The recommended dosage of Vyndaqel is 80 mg (4 × 20 mg tafamidis meglumine capsules) orally once daily. Swallow the capsules whole and not crush or cut. This medicine may be taken with or without food.
If puking occurs after dosing, and the intact Vyndaqel capsule is noticed, then an additional dose of Vyndaqel capsule should be administered if possible. If no capsule is noticed, then no additional dose of Vyndaqel is needed, with resumption of dosing the very next day as usual.
Warning & Precautions
- The vyndaqel capsule should be added to the standard of care to treat patients with ATTR-PN. Health specialists should evaluate patients and continue to assess the requirement for other therapy, including the requirement for liver transplantation, as part of this standard of care.
- As there are no evidence exist regarding the use of tafamidis meglumine capsules post-liver transplantation, use of tafamidis meglumine should be stopped in those who undergo liver transplantation.
- The medicine vyndaqel 20 mg contains no more than 44mg sorbitol in each capsule. Sorbitol is a source of fructose. The additive effect of concomitantly used products containing sorbitol and dietary intake of sorbitol should be taken into account. The content of sorbitol in medicine for oral use may affect the bioavailability of other medicines for oral use administered concomitantly.
- Findings suggest that Vyndaqel treatment may cause fetal harm if administered to a pregnant woman. Pregnancy planning as well as prevention should be considered for females of reproductive age/potential.
- Available findings/data have shown excretion of tafamidis in human milk. A risk to the newborns or infants cannot be excluded. It is not advisable to use tafamidis meglumine during breast-feeding.
- Depending on the pharmacokinetic as well as pharmacodynamic profile, tafamidis meglumine is believed to have no or negligible influence on the potential to drive or operate machines.
Documentation & Availability
What documents are required to import VYNDAQEL to India?
VYNDAQEL (Tafamidis Meglumine) Capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is VYNDAQEL available in India?
VYNDAQEL (tafamidis meglumine capsule) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the basis of Named Patient Supply (NPS). S S Healthcare is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
VYNDAQEL can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of VYNDAQEL (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for vyndaqel price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the VYNDAQEL (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Vyndaqel®?
Tafamidis Meglumine is Generic Name for the trade name drug Vyndaqel®.
What is the Manufacturer Name of Vyndaqel®?
Vyndaqel® is manufactured by Pfizer Inc.
Is Vyndaqel® approved by the FDA?
Yes, Vyndaqel® is approved by the FDA. Date of approval: 3 May 2019.
What is the dosage and form of Vyndaqel® supplied?
Vyndaqel® is supplied as Capsules: 20 mg for oral administration.
Is Vyndaqel the same as Vyndamax?
Yes. Both Vyndaqel and Vyndamax typically contain the same active ingredient named tafamidis.
What is the difference between Vyndaqel and Vyndamax?
The difference between Vyndaqel and Vyndamax capsule typically lies in the form of tafamidis they contain. Vyndaqel is a composition of micronized meglumine salt of tafamidis, while Vyndamax is a composition of free acid form of tafamidis.
What are the most common side effects with Vyndaqel®?
The most common side effects with Vyndaqel® include: vomiting, nausea, alopecia, abdominal pain, constipation, decreased appetite, palmar-plantar erythrodysesthesia, fatigue, myalgia, and diarrhea.
How much does Vyndaqel® cost in India?
Cost of vyndaqel 20 mg capsule in India is reasonable and can vary. In order to procure this transthyretin stabilizer authentically, you can Call/WhatsApp: +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Vyndaqel®?
Store Vyndaqel at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
Is it safe to buy Vyndaqel® online from India?
Yes, You can buy Vyndaqel online from India authentically from https://www.indianpharmanetwork.in/ if this drug is not available or has not been approved in your home country.
What are the Highlights of prescribing information for Vyndaqel®?
Click Here to download full Vyndaqel prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
